COVID-19 Resources 

Experimental Agent Reviews

Members from the Society of Infectious Diseases Pharmacists have prepared brief, evidence-based reviews of potential pharmacotherapeutic treatment options for COVID-19. These video presentations and handouts will be updated regularly as new data emerge on each of these experimental therapies. 


A Message from the SIDP President

Jason M. Pogue, PharmD, BCPS, BCIDP 



Handouts

Below are links to 10-20 minute educational treatment presentations on each agent listed. 

Remdesivir (GS-5734) 

Speaker: Matt Davis, PharmD

 Handouts


Chloroquine & Hydroxychloroquine

Speaker: Zahra Kassamali Escobar, PharmD, BCIDP

     

Handouts

Ribavirin 

Speaker: Julie Ann Justo, PharmD, MS, BCPS-AQ ID

   

 Handouts  


Tocilizumab (Actemra®)

Speaker: Ana D. Vega, PharmD, BCIDP


Handouts

Lopinavir/ritonavir (Kaletra®)

Speaker: Krutika Mediwala, PharmD, BCPS, BCIDP

 

Handouts

 

To view all presentations on COVID-19, please click the link below. 

COVID-19 Videos


COVID-19 Literature

COVID-19 Treatment: A Review of Early and Emerging Options

A helpful review article published online on March 23, 2020 by Erin K. McCreary, PharmD, BCPS, BCIDP and Jason M. Pogue, PharmD, BCPS, BCIDP on behalf of SIDP


Society of Infectious Diseases Pharmacists • 121 W. State Street, Geneva, IL 60134
(630) 938-4732 sidp@affinity-strategies.com
Proudly Managed by Affinity Strategies

Powered by Wild Apricot Membership Software